IBDEI0E4 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6160,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,6160,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,6160,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,6161,0)
 ;;=N52.8^^40^384^11
 ;;^UTILITY(U,$J,358.3,6161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6161,1,3,0)
 ;;=3^Erectile Dysfunction NEC
 ;;^UTILITY(U,$J,358.3,6161,1,4,0)
 ;;=4^N52.8
 ;;^UTILITY(U,$J,358.3,6161,2)
 ;;=^5015762
 ;;^UTILITY(U,$J,358.3,6162,0)
 ;;=N52.39^^40^384^15
 ;;^UTILITY(U,$J,358.3,6162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6162,1,3,0)
 ;;=3^Erectile Dysfunction,Post-Surgical NEC
 ;;^UTILITY(U,$J,358.3,6162,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,6162,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,6163,0)
 ;;=N52.34^^40^384^9
 ;;^UTILITY(U,$J,358.3,6163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6163,1,3,0)
 ;;=3^Erectile Dysfunction Following Simple Prostatectomy
 ;;^UTILITY(U,$J,358.3,6163,1,4,0)
 ;;=4^N52.34
 ;;^UTILITY(U,$J,358.3,6163,2)
 ;;=^5015760
 ;;^UTILITY(U,$J,358.3,6164,0)
 ;;=N52.33^^40^384^10
 ;;^UTILITY(U,$J,358.3,6164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6164,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,6164,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,6164,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,6165,0)
 ;;=N52.32^^40^384^7
 ;;^UTILITY(U,$J,358.3,6165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6165,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,6165,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,6165,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,6166,0)
 ;;=N52.31^^40^384^8
 ;;^UTILITY(U,$J,358.3,6166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6166,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,6166,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,6166,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,6167,0)
 ;;=N52.2^^40^384^14
 ;;^UTILITY(U,$J,358.3,6167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6167,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,6167,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,6167,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,6168,0)
 ;;=N52.02^^40^384^13
 ;;^UTILITY(U,$J,358.3,6168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6168,1,3,0)
 ;;=3^Erectile Dysfunction,Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,6168,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,6168,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,6169,0)
 ;;=N52.03^^40^384^12
 ;;^UTILITY(U,$J,358.3,6169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6169,1,3,0)
 ;;=3^Erectile Dysfunction,Artrl Insuff/Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,6169,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,6169,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,6170,0)
 ;;=N52.1^^40^384^18
 ;;^UTILITY(U,$J,358.3,6170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6170,1,3,0)
 ;;=3^Eriectile Dysfunction d/t Oth Diseases
 ;;^UTILITY(U,$J,358.3,6170,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,6170,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,6171,0)
 ;;=N52.01^^40^384^17
 ;;^UTILITY(U,$J,358.3,6171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6171,1,3,0)
 ;;=3^Eriectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,6171,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,6171,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,6172,0)
 ;;=R33.9^^40^384^34
 ;;^UTILITY(U,$J,358.3,6172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6172,1,3,0)
 ;;=3^Retention of Urine,Unspec
 ;;^UTILITY(U,$J,358.3,6172,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,6172,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,6173,0)
 ;;=R32.^^40^384^38
